Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Skin Neoplasms × reolysin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 5 Breast Neoplasms 4 Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Fallopian Tube Neoplasms 2 Carcinoma 2 Unspecified Childhood Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Skin Neoplasms 1 Sarcoma, Synovial 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Osteosarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Glioma 1 Glioblastoma 1 Fibrosarcoma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Anemia 1 Adenocarcinoma 1

Interventions

pembrolizumab 19 aldesleukin 19 Nivolumab 19 Cyclophosphamide 18 Ipilimumab 16 fludarabine 14 Interleukin-2 14 fludarabine phosphate 12 cemiplimab 11 Radiotherapy 7 Fluorouracil 6 Dacarbazine 6 Vemurafenib 5 Radiation 5 Biopsy 5 Aminolevulinic Acid 5 dabrafenib 4 binimetinib 4 Temozolomide 4 Surgical Procedures, Operative 4 Sirolimus 4 Educational Status 4 trametinib 3 sonidegib 3 montanide ISA 51 3 encorafenib 3 avelumab 3 Sodium Chloride 3 Semaxinib 3 Photochemotherapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03282188 2018-05-04

REO13 Melanoma With of Without GM-CSF

University of Leeds

Phase 1/2 Withdrawn

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡